emerg
middl
east
respiratori
syndrom
coronaviru
merscov
continu
threat
global
human
health
twentyseven
countri
report
human
case
merscov
case
occur
individu
return
travel
arabian
peninsula
contact
someon
return
arabian
peninsula
http
wwwwhointemergenciesmerscoven
may
singl
individu
return
travel
arabian
peninsula
initi
epidem
south
korea
infect
peopl
result
sinc
januari
countri
within
arabian
peninsula
report
monthli
case
merscov
origin
either
human
contact
infect
individu
contact
dromedari
camel
consid
intermedi
zoonot
host
http
wwwcidrapumnedu
infect
individu
typic
present
respiratori
symptom
progress
sever
pulmonari
diseas
associ
mortal
rate
report
despit
threat
global
public
health
prevent
humantohuman
transmiss
continu
reli
upon
standard
public
healthcar
practic
oxygen
supplement
mechan
respiratori
support
infect
individu
experienc
sever
pulmonari
antim
therapeut
vaccin
countermeasur
gradual
advanc
toward
clinic
review
howev
effect
evalu
antim
countermeasur
hamper
recent
avail
anim
model
reflect
sever
pulmonari
complic
observ
human
approxim
incub
period
mer
day
rang
day
patient
present
overt
diseas
develop
fever
cough
short
breath
sever
pulmonari
diseas
human
associ
detect
high
viral
load
tracheal
aspir
sputum
throat
swab
blood
recoveri
sever
respiratori
diseas
may
associ
antibodi
cell
publicli
avail
autopsi
report
indic
lower
respiratori
tract
lrt
infect
result
xray
radiographi
ct
patient
also
indic
lrt
diseas
pneumonia
promin
find
review
viral
load
highest
tracheal
aspir
may
contain
increas
materi
lrt
base
ciliari
motion
therefor
anim
model
achiev
pneumonia
high
viral
load
trachea
lower
respiratori
tract
lrt
import
aspect
fulli
recapitul
sever
human
diseas
three
differ
research
group
establish
model
merscov
infect
two
nonhuman
primat
nhp
rhesu
macaqu
common
infect
lrt
could
establish
use
differ
invas
strategi
placement
challeng
rang
clinic
outcom
includ
mild
respiratori
diseas
detect
use
comput
tomographi
radiograph
sever
respiratori
diseas
produc
clinic
endpoint
indic
fatal
diseas
requir
euthanasia
two
common
marmoset
two
group
observ
lethal
diseas
follow
intratrach
intranas
ocular
exposur
mersemc
isol
howev
chan
et
al
indic
lethal
could
due
manipul
marmoset
less
hardi
macaqu
third
group
observ
mild
moder
diseas
use
higher
viral
titer
mersjordan
isol
singl
rout
experi
rhesu
monkey
use
indic
rhesu
develop
transient
diseas
peak
day
postinfect
clear
day
howev
gross
histopatholog
collect
peak
diseas
viral
load
peak
period
marmoset
rhesu
model
subject
euthan
earli
time
point
diseas
progress
use
demonstr
antivir
efficaci
measur
differ
viral
overal
dispar
clinic
outcom
indic
human
strain
merscov
use
studi
emc
jordan
may
suitabl
adapt
nhp
therebi
make
difficult
routin
establish
high
viral
load
lrt
understand
may
difficult
establish
infect
nhp
wildtyp
human
merscov
strain
investig
use
novel
merscov
infecti
clone
previou
studi
infecti
clone
exhibit
enhanc
replic
kinet
higher
titer
emc
infecti
clone
monkey
kidney
cell
replic
higher
titer
emc
lung
infect
enhanc
replic
profil
made
attract
option
establish
infect
rhesu
macaqu
model
intratrach
exposur
elicit
radiolog
patholog
sign
mild
respiratori
diseas
rhesu
macaqu
first
studi
demonstr
capac
merscov
infecti
clone
elicit
sign
respiratori
diseas
nhp
model
work
present
expand
util
merscov
revers
genet
system
use
nhp
model
comput
tomographi
ct
imag
highli
sensit
techniqu
evalu
tissu
patholog
alter
pulmonari
patholog
chang
quantifi
measur
intens
hyperdens
voxel
total
lung
volum
cours
diseas
also
refer
percent
chang
lung
hyperdens
pclh
area
hyperdens
repres
chang
lung
tissu
associ
lung
patholog
exhibit
obviou
increas
pclh
day
gradual
resolut
day
postinfect
fig
except
increas
pclh
readili
detect
baselin
nhp
cours
diseas
fig
exhibit
chang
pclh
cours
experi
experienc
increas
observ
prior
nhp
infect
wildtyp
merscov
strain
must
note
improp
endotrach
tube
placement
artifici
exagger
lung
diseas
day
imag
session
quantit
measur
hyperdens
region
indic
peak
day
postinfect
pi
nhp
develop
multifoc
lung
patholog
gradual
resolv
day
pi
fig
nevertheless
ct
demonstr
exposur
result
quantifi
increas
lung
patholog
sever
previous
observ
wildtyp
human
notabl
diseas
rhesu
monkey
constitut
mild
respiratori
infect
compar
pclh
recalcul
data
obtain
previou
studi
follow
infect
emc
supplement
fig
grossli
anim
euthan
day
postinocul
pi
diffus
mild
pulmonari
congest
fig
histolog
anim
focaltodiffus
minimaltomild
interstiti
pneumonia
alveoli
line
hyperplast
type
ii
pneumocyt
fill
fibrin
edema
red
blood
cell
macrophag
septa
minimallytomildli
expand
fibrin
proteinac
fluid
mononuclear
cell
fig
multifoc
alveoli
often
expand
fill
eosinophil
fibrillar
materi
septa
show
minim
mild
smooth
muscl
cell
hyperplasia
fibrosi
vascular
congest
fig
three
anim
necropsi
day
pi
show
signific
lung
lesion
fig
quantit
microscop
find
lung
commensur
histopatholog
find
supplement
tabl
extrapulmonari
tissu
exhibit
incident
histolog
chang
supplement
tabl
scarc
number
pneumocyt
perivascular
inflammatori
cell
fig
epitheli
cell
submucos
gland
lymphoid
aggreg
fig
posit
mer
spike
protein
anim
euthan
day
pi
lung
anim
day
pi
epitheli
cell
submucos
gland
bronchi
cell
balt
posit
mer
spike
antigen
fig
dual
immunohistochemistri
stain
mer
spike
demonstr
mer
posit
posit
cell
subject
day
pi
three
subject
neg
day
postinfect
fig
e
rel
alveolar
macrophag
promin
day
pi
day
pi
contrast
epitheli
cell
submucos
gland
antigen
posit
cell
dpi
group
dpi
group
small
number
antigen
posit
cell
increas
opportun
error
lower
lung
aspir
sampl
rna
analysi
may
account
inabl
detect
mer
viral
rna
qrtpcr
lung
aspir
supplement
tabl
focus
rna
isol
sampl
previous
identifi
posit
ihc
detect
formalinfix
paraffinembed
ffpe
lung
tissu
tabl
primer
set
detect
fulllength
genom
subgenom
rna
wherea
leaderorfn
combin
detect
subgenom
replic
rna
infect
cell
subgenom
rna
detect
dpi
group
dpi
group
indic
higher
level
infect
dpi
tabl
nonetheless
detect
rna
dpi
group
may
indic
viral
adapt
possibl
replic
studi
would
requir
confirm
hypothesi
experi
demonstr
infecti
clone
deriv
merscov
pathogen
wildtyp
merscov
jordan
isol
use
previou
rhesu
experi
also
demonstr
diseas
elicit
infect
rhesu
peak
postexposur
resolv
postexposur
infect
correspond
enhanc
number
alveolar
macrophag
identifi
postexposur
rel
day
postexposur
similar
data
previous
report
rhesu
macaqu
data
support
avail
merscov
nhp
model
recapitul
human
diseas
adapt
merscov
nhp
may
provid
suitabl
nhp
model
absenc
nhp
model
reflect
sever
pulmonari
diseas
measur
clinic
endpoint
noninvas
method
quantifi
merscovinduc
lung
diseas
import
previou
studi
group
demonstr
kinet
merscovinduc
mild
lung
diseas
readili
measur
use
ct
imag
combin
quantit
previou
studi
merscov
jordan
strain
rhesu
model
establish
rang
valu
pclh
current
studi
strain
exhibit
increas
pclh
anim
compar
obtain
jordan
strain
prior
rhesu
studi
enhanc
pclh
indic
may
exhibit
augment
pathogenesi
compar
wildtyp
strain
rhesu
model
albeit
addit
studi
directli
compar
wildtyp
strain
would
benefici
despit
enhanc
pathogenesi
diseas
consid
mild
compar
pclh
level
achiev
rhesu
model
smallpox
util
cowpox
pclh
level
fold
higher
rhesu
smallpox
model
commensur
overt
sign
sever
respiratori
diseas
mortal
dispar
outcom
pulmonari
diseas
sever
indic
merscov
may
adapt
overcom
host
immun
mechan
preclud
merscov
pathogenesi
rhesu
model
two
approach
may
facilit
develop
model
reproduc
recapitul
human
merscov
pathogenesi
alter
nhp
host
one
suscept
merscov
infect
pathogenesi
ii
adapt
merscov
rhesu
model
common
marmoset
may
tractabl
nhp
model
investig
merscov
sever
respiratori
diseas
marmoset
model
compar
rhesu
model
reproduc
observ
among
group
develop
pathogen
nhp
model
two
group
report
sever
respiratori
diseas
marmoset
clinic
endpoint
criteria
indic
lethal
diseas
requir
third
studi
jordan
emc
wildtyp
merscov
strain
exhibit
larg
increas
volum
lung
tissu
patholog
chang
measur
ct
direct
quantit
comparison
lesion
volum
rhesu
marmoset
complic
differ
anim
lung
volum
rapid
breath
rate
marmoset
compar
rhesu
nonetheless
abl
util
data
previous
obtain
follow
infect
marmoset
emc
calcul
pclh
level
manner
similar
obtain
rhesu
monkey
supplement
fig
higher
pclh
level
marmoset
indic
effect
diseas
achiev
marmoset
accordingli
propos
strain
may
elicit
sever
respiratori
diseas
marmoset
model
observ
current
studi
technic
differ
facilit
effect
deliveri
viru
marmoset
model
host
genet
variat
marmoset
facilit
infect
host
genet
variat
rhesu
macaqu
curb
infect
may
contribut
differ
virul
observ
two
model
sinc
difficult
control
variat
host
genet
outbr
nhp
model
system
adapt
merscov
rhesu
model
may
feasibl
option
circumv
obstacl
avail
anim
known
reagent
increas
feasibl
enhanc
attract
rhesu
model
regardless
propos
experi
meet
recommend
potenti
pandem
pathogen
care
oversight
polici
guidanc
http
rel
higher
number
spike
protein
posit
cell
detect
rna
epitheli
cell
submucos
gland
dpi
absenc
inflammatori
cell
suggest
possibl
viru
may
acquir
mutat
facilit
longterm
viral
mainten
without
immun
detect
increas
number
merscov
infect
cell
submucosa
agre
previou
report
demonstr
robust
express
receptor
human
submucos
gland
epithelia
compar
littl
express
epithelia
conduct
isol
merscov
submucos
gland
could
serv
viral
sourc
subsequ
adapt
rhesu
macaqu
passag
pigtail
macaqu
establish
preced
adapt
virus
monkey
passag
requir
achiev
nhp
model
recapitul
aid
observ
studi
would
necessari
directli
confirm
persist
low
level
merscov
replic
nonetheless
novel
mutat
identifi
sequenc
merscov
rna
lung
could
incorpor
merscov
genom
gener
novel
infecti
clone
subsequ
passag
might
yield
improv
rhesu
model
moreov
recombin
viru
produc
diseas
primat
provid
strategi
evalu
viru
genet
contribut
diseas
sever
nhp
model
reproduc
recapitul
lethal
human
diseas
follow
respiratori
infect
may
effect
evalu
merscov
countermeasur
may
oversimplif
number
preexist
condit
may
contribut
individu
suscept
merscov
increas
age
sever
comorbid
eg
diabet
hypertens
chronic
respiratori
diseas
etc
commonli
associ
individu
develop
sever
respiratori
diseas
follow
merscov
infect
review
captur
complex
phenotyp
diseas
model
may
prove
difficult
cost
effect
combin
captur
complex
phenotyp
inabl
control
host
genet
variat
outbr
nhp
popul
indic
manipul
host
may
prove
difficult
therefor
alter
merscov
genom
adapt
may
feasibl
option
achiev
reproduc
nhp
model
strain
demonstr
feasibl
introduc
novel
genet
chang
merscov
genom
augment
respiratori
diseas
phenotyp
simpl
random
use
select
anim
depopul
earli
estim
peak
diseas
reduc
risk
decis
bia
studi
outcom
random
perform
use
rand
function
excel
assign
number
nhp
anim
associ
three
highest
result
rand
function
select
sacrific
day
prepar
viru
inoculum
quantif
challeng
dose
mer
use
challeng
studi
ideal
viru
inoculum
target
pfuml
conform
histor
studi
viru
inoculum
use
undilut
initi
viru
stock
titer
quantifi
pfuml
averag
two
independ
plaqu
assay
vero
cell
atcc
viru
inoculum
backtitr
use
standard
avicel
fmc
biopolym
semisolid
plaqu
assay
method
briefli
viru
inoculum
serial
dilut
halflog
increment
minim
essenti
medium
alpha
gibco
supplement
antianti
gibco
heatinactiv
fetal
bovin
serum
fb
gibco
threehundr
microlit
sampl
assay
nearconflu
plate
vero
cell
atcc
h
gentl
agit
everi
minut
prevent
dri
monolay
follow
adsorpt
ml
mixtur
eagl
minim
essenti
medium
gibco
avicel
ad
well
plate
return
incub
plate
count
enumer
remov
overlay
stain
gentian
violet
solut
prepar
neutral
buffer
formalin
minut
rins
dri
plate
six
rhesu
monkey
five
previous
survivor
ebola
viru
studi
evalu
efficaci
polyclon
transgen
bovin
antibodi
treatment
use
studi
day
postebola
viru
infect
anim
singli
hous
durat
experi
identifi
cage
card
tattoo
mark
anim
observ
least
daili
follow
viru
exposur
anim
experi
perform
laboratori
approv
niaid
divis
clinic
research
institut
anim
care
use
committe
perform
aaalac
intern
accredit
facil
accord
relev
nih
polici
anim
welfar
act
regul
anim
anesthet
immobil
squeez
back
cage
facilit
intramuscular
deliveri
ketamin
prior
anim
handl
includ
physic
exam
viru
exposur
viru
exposur
perform
use
bronchoscop
introduc
flexibl
tube
connect
stop
cock
deposit
ml
inoculum
syring
left
bronchu
tube
flush
air
use
syring
ensur
deliveri
entir
volum
process
repeat
introduc
addit
ml
inoculum
right
bronchu
anim
initi
anesthet
use
ketamin
anesthesia
maintain
intraven
propofol
anim
intub
facilit
breath
hold
imag
clariti
lung
field
ct
imag
acquir
use
philip
gemini
ct
scanner
imag
analysi
perform
use
percent
chang
lung
hyperdens
analysi
pclh
solomon
et
al
ieee
intern
symposium
computerbas
medic
system
hyperdens
volum
percent
total
lung
volum
calcul
hyperdens
tissu
volumetot
lung
volum
analysi
exist
marmoset
data
set
perform
manner
blood
collect
clotactiv
tube
contain
silica
bead
anticoagul
clotactiv
tube
allow
clot
least
minut
prior
process
blood
tube
centrifug
relativecentrifug
forc
separ
serum
plasma
upstream
chemistri
analysi
perform
use
piccolo
gener
chemistri
disc
piccolo
xpress
analyz
complet
blood
count
use
sysmex
nasal
swab
collect
use
bd
viral
transport
system
briefli
swab
insert
nare
immedi
transfer
collect
tube
contain
viru
stabil
medium
use
steril
techniqu
swab
vortex
vigor
second
lung
tissu
sampl
collect
proxim
bronchial
branch
homogen
bead
beater
tube
use
omniruptor
clarifi
centrifug
prior
inactiv
supernat
inactiv
trizol
ls
accord
manufactur
instruct
rna
nhp
lung
aspir
harvest
trizol
isol
use
zymo
directzol
rna
miniprep
kit
zymo
research
corp
irvin
ca
usa
accord
manufactur
direct
rna
isol
formalinfix
paraffinembed
lung
tissu
use
qiagen
rneasi
formalinfix
paraffinembed
kit
accord
manufactur
instruct
qiagen
firststrand
cdna
gener
use
superscript
iii
revers
transcriptas
life
technolog
carlsbad
ca
usa
quantif
viral
genom
subgenom
rna
realtim
pcr
perform
use
sybrbas
ssofast
evagreen
supermix
biorad
hercul
ca
usa
roch
lightcycl
roch
basel
switzerland
realtim
reaction
use
primer
set
specif
detect
genom
rna
nucleocapsidencod
subgenom
rna
orfn
list
supplement
result
normal
eukaryot
analyz
use
method
anim
underw
extens
postmortem
necropsi
qualifi
pathologist
anim
overal
gener
condit
state
major
organ
system
assess
tissu
trim
cubic
centimet
submerg
fix
neutral
buffer
formalin
day
paraffin
embed
tissu
section
mount
positivelycharg
slide
stain
hematoxylin
eosin
prior
patholog
examin
immunohistochemistri
target
merscov
spike
protein
perform
lung
tissu
sampl
tissu
slide
subject
heatinduc
antigen
retriev
citrat
base
buffer
minut
biocar
medic
cat
protein
block
biocar
medic
cat
immunostain
perform
use
primari
rabbit
polyclon
antibodi
specif
merscov
spike
protein
sino
biolog
cat
dilut
follow
secondari
biotinyl
goat
antirabbit
igg
jackson
immunoresearch
cat
dilut
resolv
use
vectastain
elit
abc
hrp
kit
vector
lab
cat
betazoid
dab
kit
biocar
medic
cat
sequenti
doubl
stain
carri
formalinfix
paraffinembed
lung
section
use
goat
polyclon
r
system
cat
mous
monoclon
antim
cov
nucleocapsid
np
protein
biorbyt
llc
ca
protocol
complet
bond
rx
leica
biosystem
platform
briefli
section
deparaffin
rehydr
heatinduc
epitop
retriev
hier
perform
use
epitop
retriev
solut
ph
heat
minut
specimen
incub
hydrogen
peroxid
quench
endogen
peroxidas
activ
prior
appli
minut
detect
dab
chromogen
complet
use
bond
polym
refin
detect
kit
leica
biosystem
cat
post
primari
step
replac
eightminut
incub
rabbit
antigoat
secondari
antibodi
abcam
cat
antim
np
appli
minut
fast
red
detect
perform
bond
polym
refin
red
detect
kit
leica
biosystem
cat
includ
counterstain
hematoxylin
slide
final
clear
gradient
alcohol
xylen
wash
prior
mount
coverslip
section
examin
boardcertifi
veterinari
pathologist
inm
use
olympu
light
microscop
photomicrograph
taken
use
olympu
camera
